| Casey Humes, PHARMD | |
|
1031 Grand Avenue, Beattyville, KY 41311 | |
| (606) 464-3396 | |
| Not Available |
| Full Name | Casey Humes |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1031 Grand Avenue, Beattyville, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235885948 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 018734 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Casey Humes, PHARMD 1031 Grand Avenue, Beattyville, KY 41311 Ph: () - | Casey Humes, PHARMD 1031 Grand Avenue, Beattyville, KY 41311 Ph: (606) 464-3396 |
News Archive
A new study published in JAMA on CT colonography or 'virtual' colonoscopy using 2-D imaging finds that this test lacks the sensitivity and specificity of conventional colonoscopy for colorectal cancer screening. Study co-author and American College of Gastroenterology President Douglas K. Rex, M.D. is available for interviews.
Cranfield University researchers in partnership with Meditech Gloves, one of the leading manufacturers of high-quality examination and surgical gloves, have shown how energy savings can be made with the development of more sustainable, biodegradable, protein-free, natural rubber gloves.
Ligand Pharmaceuticals Incorporated today announced that data from a Phase I study with its selective androgen receptor modulator (SARM) LGD-4033 was featured today in a poster presentation at the 14th International Congress of Endocrinology in Kyoto, Japan. This Phase I clinical trial was the first study in humans of LGD-4033, and evaluated the safety, tolerability and pharmacokinetic profiles of the molecule in a single escalating dose, double blind, placebo-controlled study in 48 healthy volunteers.
ARIAD Pharmaceuticals, Inc. (Nasdaq: ARIA) today announced data from a Phase 1 clinical trial evaluating oral ridaforolimus, its investigational mTOR inhibitor, in combination with bevacizumab (Avastin®) in heavily pretreated patients with refractory metastatic solid tumors. The data were presented at the Joint Multidisciplinary Congress of the 15th annual European Cancer Organization (ECCO) and the 34th annual European Society of Medical Oncology (ESMO) taking place in Berlin, Germany.
Daniel H. Solomon, M.D., M.P.H., from Brigham and Women's Hospital, Boston, and Jerry Avorn, M.D., of Harvard University School of Medicine, write in the January 24 issue of Archives of Internal Medicine that the withdrawal of rofecoxib (Vioxx) from the market in September 2004 by its manufacturer, Merck & Co., "raises many questions concerning drug policy, scientific evidence, and treatment alternatives.
› Verified 5 days ago
Misty Kristina Woods-bolton, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 31 Big Hill Dr, Beattyville, KY 41311 Phone: 606-464-2581 | |
Justin Riffle, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1075 Highway 11 N, Beattyville, KY 41311 Phone: 606-464-3656 | |
Whitney Blackwell, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 111 River Drive, Beattyville, KY 41311 Phone: 606-464-3656 Fax: 606-464-9002 | |
Makenzie Lexis Neace, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 31 Big Hill Dr, Beattyville, KY 41311 Phone: 606-464-2581 | |
Debra Litteral Napier, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1071 Hwy 11 North, Beattyville, KY 41311 Phone: 800-867-1840 Fax: 800-867-1841 | |
Mr. Luther G Smith, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1075 Broadway St., Beattyville, KY 41311 Phone: 606-464-3901 Fax: 606-464-8888 |